Meet the team
President and CEO
Young founded RODO Medical in Sunnyvale, California in 2009. He assembled a team of many seasoned professionals in the medical device industry and raised a seed round from a group of dentists who became very excited about the concept. (Ultimately, they would also become the device users.) Shortly after delivering the proof of concept, Young led the company to: raise the series A round from high-net-worth individuals in 2010, complete the first generation product in 2011, and obtain a CE Mark in 2012.
Prior to RODO Medical, Young co-founded Enview Technologies in 2001, which was incubated from his Ph.D. thesis into a patented technology in the automotive industry. Young holds a Ph.D. in Mechanical Engineering from the University of Michigan.
Executive Vice President Corporate Development, General Counsel and Corporate Secretary
Michael has over 20 years of business and legal experience. Prior to joining Rodo Medical, he served as Executive Vice President, General Counsel, and Corporate Secretary of Onpharma Inc., a pharmaceutical and medical device company that developed an innovative buffering solution to vastly improve the efficacy and speed of local anesthesia. Onpharma was acquired by Valeant Pharmaceuticals (NYSE: VRX) in March 2014.
Prior to Onpharma, Michael served as Vice President and General Counsel at Telocity Inc. and DirecTV Broadband (a subsidiary of Hughes Electronics). He has experience in financing transactions, investor relations, and served as a trial and corporate law attorney in San Jose, CA. Michael has a BA in Pre-Law from the University of California Santa Barbara, and a JD from the University of Pacific's McGeorge School of Law.
Vice President of R&D
James received BSE in Aerospace Engineering and Computer Science at University of Michigan, and MSE in Aerospace Engineering and Certificate Management of Technology at Georgia Institute of Technology. James has been working at RODO Medical since August 2009.
Senior Vice President of Sales, Marketing & Education
Gino brings over 20 years of progressive experience in sales, marketing, education and business development. His med-tech areas of focus within the dental industry have included orthodontics, cosmetic/restorative dentistry, implant dentistry, biologics and the digital workflow. He has held various senior leadership roles with industry leaders including; 3M ESPE, Discus Dental (Phillips Oral Healthcare) and Straumann. Most recently, he created a unique implant patient financing portfolio of products designed to increase patient case acceptance with Lending Club.
Gino is often called upon to lecture and moderate on a number of related topics enabling dental practices to experience above-average growth and overall success. Lastly, Gino serves in advisory and consulting capacities currently with ASDOH and Launchpad Medical.
Ben Wu, DDS, PhD
Chief Clinical Officer
Ben Wu is is an internationally renowned innovator and leader in dentistry and bioengineering and brings unique expertise with the RODO core technology to our Scientific Advisory Board.
He is Professor and Chair of the Division of Advanced Prosthodontics, and the Director of the Weintraub Center for Reconstructive Biotechnology at the UCLA School of Dentistry. He also chaired the Department of Bioengineering at UCLA School of Engineering, and holds formal faculty appointments in the Department of Orthopedic Surgery and the Department of Materials Science. All four departments are highly ranked within their respective disciplines.
Ben obtained his residency training in Advanced Prosthodontics at Harvard, and his Ph.D. in Materials Engineering at the Massachusetts Institute of Technology. At MIT, he investigated the powder-binder interaction physics for 3D Printing of biomedical relevant materials, and published the first papers on 3D Printed drug delivery devices and tissue engineering scaffolds. His research applies bioengineering approaches to regenerate lost tissues and control wound healing by developing biomimetic strategies. He has also developed advanced material processing technologies to enable the production of novel structures and functions; and created novel medical devices that will impact the way we diagnose and treat diseases.
As a clinician, Dr. Wu provides multidisciplinary patient care in the UCLA Faculty Group Dental Practice, where he focuses on the treatment of advanced, complex oral rehabilitation using implant, fixed, and removable prosthodontics. He is a fellow of the Academy of Prosthodontics, and serves on numerous advisory committees in academia and industry.
Board of Directors
Amir has over 26 years of operating experience in the healthcare industry focused on developing and commercializing cardiovascular devices, dental products, hearing prosthetics, and genomic diagnostics & analytics. Amir was the inventor and founder of Sonitus Medical in 2006, a novel non-surgical hearing prosthetic. Prior to Sonitus, Amir served for six years as Vice President of R&D at Align Technology Inc. (NASDAQ: ALGN), creators of a unique, invisible orthodontic product called Invisalign.
Amir has over 100+ issued patents. He received a MS in Engineering Management from University of Southern California and BS in Biomedical Engineering from University of California, San Diego.
Having obtained a Bachelor’s degree in Physics from the University of Dijon and a Masters in Marketing from FGE in Tours, Guillaume Daniellot completed his studies with a Masters in Business Administration at the ESC European School of Management in Paris.
His professional career began in hospital product management – initially at Coloplast and then at B. Braun, as an international business unit manager. He switched to the dental industry in 2001, joining Dentsply France, where he became Sales & Marketing Director.
Mr Daniellot joined Straumann in 2007 as Managing Director of Straumann France. Two years later, he transferred to Group Headquarters to become Head of Global Sales Digital Dentistry. Shortly afterwards he took over responsibility for Straumann’s Prosthetic Laboratory Business Group, including global management of sales, marketing, product development, training and education. In both these roles he was a member of the Corporate Management Group. He joined Straumann’s Executive Management Board (EMB) as Head Sales Western Europe in 2013.
Greg Garfield is an executive with extensive experience in running medical technology companies, including managing and leading people at all levels, as well operational management and business strategy and planning. Originally an attorney at Pillsbury Winthrop, Greg began his medical technology career at Guidant Corporation where he held a number of executive-level legal and business development positions in different Guidant operating companies. Following Guidants acquisition by Boston Scientific, Greg joined Acclarent, Inc. where he served initially as Vice President of Corporate Development, and then as Acclarents Chief Operating Officer through the acquisition and integration of Acclarent by Ethicon, Inc., a Johnson & Johnson company. In addition to RODO Medical, Greg currently serves on the Board of Directors of Sonitus Medical, C2 Therapeutics and Aerin Medical.
Frank Hemm holds a Master’s degree in Economics from the University of St. Gallen and a Master’s in Business Administration from Kellogg Graduate School of Management in the USA. His business career began in management consulting with Andersen Consulting and McKinsey, focusing on business process re-engineering and strategic management consulting.
Mr Hemm joined Straumann in 2004 and was initially responsible for Corporate Business Development & Licensing. He was appointed Head of Sales, Western Europe in 2007 and became a member of the Corporate Management Group. A year later, he was given responsibility for the Asia/Pacific Region as Head of Sales based in Singapore, where he established and built up Straumann’s regional headquarters. In addition to leading the integration and turnaround of the acquired distributors in Japan and Korea, he also expanded Straumann’s presence in China.
In 2012, Mr Hemm was appointed to the Executive Management Board as Head of EMEA and LATAM, and he moved into his current role in 2013.
Kevin Mosher is an executive with more than 20 years experience in the dental and medical technology industries, and currently serves as President & CEO of ClearChoice Holdings, a nationwide network of dental implant centers that specialize in the treatment of the fully edentulous. Following a five-year stint as a logistics officer in the US Navy, Kevin began his medical career in sales and marketing with Baxter Healthcare, Johnson & Johnson (Ethicon and Advanced Sterilization Products), and Masimo Corporation. As President of startup medical device manufacturer Masimo Corp, Kevin led the commercial activities of an organization that grew from $12 $70M during his three-year tenure. Following Masimo, he served as President of dental implant manufacturer Nobel Biocares North American division where divisional revenues more than doubled from $140M to $315M over a six-year period. Prior to his current position at ClearChoice, Kevin served as President & CEO of medical device startup DFINE, Inc, a company focused on the minimally invasive treatment of diseases of the spine. He holds a B.S. in Applied Engineering Sciences from the U.S. Naval Academy.
Dr. Young Seo has 10 years of experience in building technology-focused startup companies. He received his PhD in Mechanical Engineering from the University of Michigan in Ann Arbor, MI. He also co-founded Enview Technologies, LLC (Ann Arbor, MI) in 2001 and served as Chief Technology Officer. He sits on the Advisory Board for Dunamis, Inc., an innovative software developer in the electronics industry in San Jose, CA.
Mr. Mike Winzeler has 25 years of manufacturing/management experience. Since 1997, he has served as President/CEO of Winzeler Stamping Co. located in Montpelier, OH. He co-founded Enview Technologies, LLC in 2001 and serves as its president. In addition, Mr. Winzeler has worked as a manager at Frito-Lay, Inc. and Find/SVP. He graduated from The Ohio State University in Columbus, OH and holds a BS in Industrial and Systems Engineering.
Scientific Advisory Board
Ben Wu, DDS, PhD
Chairman, RODO Scientific Advisory Board
Professor and Chairman, UCLA Division of Advanced Prosthodontics
Professor and Chairman Emeritus, UCLA Department of Bioengineering
Director, Weintraub Center for Reconstructive Biotechnology
Ben Wu is is an internationally renowned innovator and leader in dentistry and bioengineering. He is Professor and Chair of the Division of Advanced Prosthodontics, and the Director of the Weintraub Center for Reconstructive Biotechnology at the UCLA School of Dentistry. He also chaired the Department of Bioengineering at UCLA School of Engineering, and holds formal faculty appointments in the Department of Orthopedic Surgery and the Department of Materials Science. All four departments are highly ranked within their respective disciplines. Prof. Wu obtained his residency training in Advanced Prosthodontics at Harvard, and his Ph.D. in Materials Engineering at the Massachusetts Institute of Technology. At MIT, he investigated the powder-binder interaction physics for 3D Printing of biomedical relevant materials, and published the first papers on 3D Printed drug delivery devices and tissue engineering scaffolds. His research applies bioengineering approaches to regenerate lost tissues and control wound healing by developing biomimetic strategies. He has also developed advanced material processing technologies to enable the production of novel structures and functions; and created novel medical devices that will impact the way we diagnose and treat diseases. He has published over 200 journal articles and patents, and delivered over 100 lectures around the world. His innovations have resulted in commercial licenses and several start-up companies to address real world problems in dentistry and medicine.
As a clinician, Dr. Wu provides multidisciplinary patient care in the UCLA Faculty Group Dental Practice, where he focuses on the treatment of advanced, complex oral rehabilitation using implant, fixed, and removable prosthodontics. He is a fellow of the Academy of Prosthodontics, and serves on numerous advisory committees in academia and industry. In addition to his experience in prosthodontics, bioengineering, and entrepreneurship, , Dr. Wu brings unique expertise with the RODO core technology to this highly accomplished Scientific Advisory Board.
Hans-Peter Weber, D.M.D.
Member, RODO Scientific Advisory Board
Professor and Chairman, Department of Prosthodontics
Tufts University School of Dentistry
Dr. Hans-Peter Weber, D.M.D., Dr. med. dent. is Professor and Chair of the Department of Prosthodontics and Operative Dentistry at Tufts University School of Dental Medicine. Prior to Tufts, he was the Nagle Professor and Chairman of the Department of Restorative Dentistry and Biomaterials Sciences at the Harvard School of Dental Medicine. Dr. Weber holds dental degrees from the University of Berne, Switzerland (Dr. med. dent.) and the Harvard School of Dental Medicine (D.M.D.), and dual Certificates in Prosthodontics and Periodontology from the University of Berne.
Dr. Weber has contributed extensively to the scientific literature in his field and is a frequently invited lecturer at national and international meetings. He is past president of the Academy of Prosthodontics, the oldest and most elite academy in dentistry, an Honorary Member of the American College of Prosthodontists, and a Member of the Board of the International Team for Implantology (ITI). Dr. Weber also serves as Associate Editor of the journal Clinical Oral Implants Research and is on the Editorial Board of the several major journals in prosthodontics, implantology, and periodontology. Dr. Weber???s is widely considered among the preeminent experts in implant dentistry worldwide.
Clark Stanford, DDS, PhD
Member, RODO Scientific Advisory Board
Distinguished Professor and Dean, University of Illinois at Chicago College of Dentistry
Clark Stanford, DDS, PhD is Distinguished Professor and Dean at the University of Illinois at Chicago College of Dentistry. He received his DDS, Prosthodontics certificate, and PhD, at the University of Iowa. He has authored 20 book chapters, over 120 journal publications, and more than 140 research abstracts in novel bio-inspired medical device designs, novel clinical trials designs (e.g., expertise-based randomized control trial designs for chronic pain) and the development of large research teams to address complex research questions concerning chronic pain and the genetic and phenotypic outcomes of a group of birth defects concerning the Ectodermal Dysplasias. He serves on multiple national and international committees associated with the International Association for Dental Research, American Dental Association, National Foundation for Ectodermal Dysplasias, American College of Prosthodontist, and the Board of Director for the Academy of Osseointegration. Dr. Stanford is the recipient of numerous academic awards including the 2007 State of Iowa Regents Award for Faculty Excellence, the IADR Distinguished Scientist Award, and is the first and only Dentistry faculty member to hold the prestigious UIC Distinguished Professor, the University???s highest academic honor.
Steven Eckert, DDS, MS
Member, RODO Scientific Advisory Board
Director, American Board of Prosthodontics
Editor-in-Chief, International Journal of Oral and Maxillofacial Implants
Steven Eckert is currently Editor-in-Chief for the International Journal of Oral and Maxillofacial Implants and is world renowned for his expertise in implant prosthodontics. Dr. Eckert graduated from The Ohio State University College of Dentistry, and has completed a General Practice Residency at Mt. Sinai Hospital in Chicago. After his graduate training in Pprosthodontics, Maxillofacial Prosthodontics and Master of Science at the Mayo Clinic College of Medicine, he was invited to be on staff at this prestigious clinic where he rose through the ranks until he reached Professor Emeritus. A Diplomate of the American Board of Prosthodontics, a Fellow of the American College of Prosthodontics, Academy of Osseointegration, the Amercian Academy of Maxillofacial Prosthodontics, and the Acacemy of Prosthodontics and International Team for Implantology, he is currently in private practice in Minneapolis.
He is past president of the most influential organizations in dental implantology and prosthodontics, including the Academy of Osseointegration, the Amercian Academy of Maxillofacial Prosthodontics, and the Acacemy of Prosthodontics. Dr. Echert currently serves as the Director, Vice President, and examiner of the American Board of Prosthodontics.
William Giannobile, DDS, MS, DMSc
Member, RODO Scientific Advisory Board
Najjar Endowed Professor of Dentistry and Biomedical Engineering
Chair of the Department of Periodontics and Oral Medicine
University of Michigan, School of Dentistry
William Giannobile is the Najjar Endowed Professor of Dentistry and Biomedical Engineering and Chair of the Department of Periodontics and Oral Medicine at the University of Michigan School of Dentistry. He received his DDS and an MS in Oral Biology from the University of Missouri, and his certificate in Periodontology and Doctor of Medical Science in Oral Biology from Harvard University. Following a productive postdoctoral training in Molecular Biology at the Dana Farber Cancer Institute and Harvard Medical School, he joined the faculty at the University of Michigan. He has published and lectured extensively in the fields of Regenerative Medicine, Tissue Engineering, and Salivary Diagnostics as it relates to periodontal and peri-implant reconstruction. Dr. Giannobile is currently Editor-in-Chief of the Journal of Dental Research and is on the editorial boards of multiple journals. He is a fellow of the American College of Dentists and a Diplomate of the American Board of Periodontology, and past president of the American Academy of Periodontology Foundation. Dr. Giannobile has served as member of the Scientific Advisory Board for Organogenesis, OraPharma, , Colgate Oral Pharmaceuticals, Dentigenix, and BioMimetic Therapeutics. He currently serves on the Dental Products Panel of the Medical Devices Advisory Committee for the Food and Drugs Administration.
Radi M. Masri, D.D.S., M.S., Ph.D.
Member, RODO Scientific Advisory Board
Associate Professor, University of Maryland School of Dentistry
Associate Professor, University of Maryland School of Medicine
Radi Masri is Associate Professor in both the University of Maryland School of Dentistry and School of Medicine. He is Principal Investigator of a federally funded research laboratory that studies the etiology and treatment of chronic pain, and develops novel technology to improve dental therapy. Both programs are funded by prestigious NIH R01 research grants. Dr. Masri received his first dental degree (BDS) from the University of Jordan Dental School in 1997 and completed a prosthodontic residency at the University of Maryland, School of Dentistry in 2001. Dr. Masri has a Master degree in oral biology and a PhD in Biomedical Sciences, and completed a three year postdoctoral fellowship in neuroscience. He is a Diplomate of the American Board of Prosthodontics, a fellow of the American College of Prosthodontists, a member of the American Academy of Fixed Prosthodontics and a Member of the Academy of Prosthodontics. Dr. Masri serves as examiner for the American Board of Prosthodontics, and as Associate Editor-in-chief of the Journal of Prosthodontics. Dr. Masri is the recipient of numerous honors, including the BioMaryland LIFE Prize Award for the most promising invention in 2015, and the American College of Prosthodontists Clinician/Researcher Award to recognize his outstanding contributions to the welfare and advancement of the College and/or specialty of Prosthodontics. Dr. Masri brings a unique combination of innovation, academic excellence, and clinical expertise to our Scientific Advisory Board.
Clinical Advisory Board
Ole Jensen, DDS, MS
Chairman of the Clinical Advisors
Ole Jensen is a Diplomate of the American Board of Oral and Maxillofacial Surgery and a Fellow of the American Dental Society of Anesthesiology. He is interested in bone grafting, dental implants, and distraction osteogenesis. Dr. Jensen has held numerous teaching positions since the early 1980s, and is currently Clinical Assistant Professor at New York University, University of Michigan, and University of Colorado at Denver. Dr. Jensen received his bachelor???s degree from the University of Utah. He completed his DDS degree at the Northwestern University School of Dentistry, and his anesthesiology residency at the Northwestern University School of Medicine. He completed his oral and maxillofacial surgery residency at the University of Michigan. Dr. Jensen has been a guest lecturer at scores of seminars and symposia, with a strong focus on implant dentistry, bone grafting and maxillofacial surgery throughout North America, as well as in Europe and Japan. He has been involved in numerous independent research projects, is the author of three textbooks on oral surgery and more than two-dozen scientific papers and publications.
Kumar C. Shah, BDS, MS, FACP
Kumar Sha is an associate clinical professor and a Board-Certified Prosthodontist & Maxillofacial Prosthodontist in the Division of Advanced Prosthodontics at the UCLA School of Dentistry. He is the Director of the Advanced Prosthodontics Postgraduate Residency Program and also directs the pre-doctoral and graduate implant dentistry courses. In addition, he is the Director of the Advanced Prosthodontics Preceptorship and Advanced Implantology Preceptorship Programs. He is also the Director of the Faculty Group Dental Practice. Dr. Shah received his B.D.S. from Singapore, his M.S. and Certificate in Adnvaced Prosthodontics from The Ohio State University, and Certificate in Maxillofacial Prosthodontics from the legendary UCLA program in Maxillofacial Prosthodontics. He is Faculty for the Foundation for Oral Facial Fehabilitiatino. His interest is in novel methods to restore the oral functions of speech, mastication, swallowing and facial esthetics in patients with structural deformities. He led the first US clinical trials for the RODO Smileloc system, and has lecture on this topic to leading professional organizations.
Curtis E. Jansen, DDS
Curtis Jansen has an extensive past involving research and design in implant dentistry, has worked with dental implant manufacturers and has developed a number of components and procedures for implant restorations, which are being used routinely by dentists around the globe. Dr. Jansen is a recognized leader in the field of implant dentistry and lectures nationally and internationally on the subject. Dr. Jansen is a member of many professional organizations, including the American College of Prosthodontists, Academy of Osseointegration and American College of Dentists. He has practiced in Monterey, California since 1996. Dr. Jansen received a Bachelor of Arts in Biology from the University of th Pacific in 1982. In 1986, he received his Doctor of Dental Surgery Degree from the University of Southern California (USC) School of Dentistry. He then went on to receive his Certificate in Advanced Education in Prosthodontics in 1988. Dr. Jansen has served as Director of Implant Dentistry at USC and oversaw both the surgical and restorative aspects of dental implant placement and restoration.
Steve Parel DDS, FACP
Dr. Parel received his dental degree from The Medical College of Virginia in 1969. He spent one year as a general practice resident with the Veterans Administration Hospital in Richmond, which was followed by a two-year residency in Prosthodontics at the Wadsworth Veterans Administration Hospital in Los Angeles. He received his Maxillofacial Prosthetics training in Houston at the M.D. Anderson Hospital and Tumor Institute in 1973. He became a faculty member in the University of Texas System in 1975, rising to the rank of full professor in the San Antonio Medical and Dental Schools in 1978. He served as head of the Maxillofacial Prosthetics Division in the Department of Prosthodontics until 1991, which was followed by 7 years of private practice in prosthetic and implant dentistry.
Dr. Parel is a Diplomate of the American Board of Prosthodontics, the American and International College of Dentists, and is a member of many professional organizations, including the American Dental Association, the Academy of Prosthodontics, and the American College of Prosthodontics. He has been course director for osseointegration training at the University of Texas Health Science Center School of Dentistry in San Antonio, one of the four original Brånemark training centers in the United States. His literature contributions include over 45 scientific articles as principal author, and multiple textbook contributions. He was editor and co-author of Esthetics and Osseointegration.